SES
12.6.2019 08:57:07 CEST | Business Wire | Press release
SES and World Space Week Association jointly announced that SES President and CEO Steve Collar will be Honorary Chair of World Space Week 2020.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190611006082/en/
“I’m excited to chair World Space Week, the biggest space event on Earth, as it focuses global attention on the broad benefits of satellite technology to humankind,” said Collar. “At SES, we always say that we do the extraordinary in space so that our customers can do amazing things on Earth. We believe passionately in the need for content and connectivity everywhere and this belief aligns perfectly with the focus of World Space Week. Space touches the human experience in so many ways and I am proud to help highlight the impact that we, as an industry, have today and will continue to have in the future.”
“We are thrilled that SES’s Steve Collar is using his voice as an industry leader to support World Space Week,” said Dennis Stone, Association President. “Over the course of his career, Steve has demonstrated a steadfast commitment to leveraging the ingenuity of the space industry to positively impact the lives and experiences of people in every corner of the globe. We’re proud to provide him with a platform to shine a light on the important contributions of this exciting field.”
World Space Week is a United Nations-declared event held each year between 4-10 October. In 2018, World Space Week included 5,400 events in 86 nations. In 2019, World Space Week will feature the Moon, with astronomy groups globally focusing telescopes on our nearest neighbor. In 2020, World Space Week will focus on satellite technology and the key role of satellites in today’s world.
Every year, teachers use space during World Space Week to inspire students and a myriad of space events to educate the public about space activities. Collar will encourage the space and satellite industries to participate in World Space Week and will keynote an awards event to recognize top supporters.
Today, nearly 2,000 satellites support crucial functions such as broadcasting, communications and connectivity, navigation, weather forecasting and Earth observations. World Space Week 2020 will also feature new uses of satellites enabled by miniaturization and next-generation systems such as SES’s new O3b mPOWER medium Earth orbit (MEO) system.
About SES
SES is the world’s leading satellite operator with over 70 satellites in two different orbits, Geostationary Orbit (GEO) and Medium Earth Orbit (MEO). It provides a diverse range of customers with global video distribution and data connectivity services through two business units: SES Video and SES Networks. SES Video reaches over 351 million TV homes, through Direct-to-Home (DTH) platforms and cable, terrestrial, and IPTV networks globally. The SES Video portfolio includes MX1, a leading media service provider offering a full suite of innovative services for both linear and digital distribution, and the ASTRA satellite system, which has the largest DTH television reach in Europe. SES Networks provides global managed data services, connecting people in a variety of sectors including telecommunications, maritime, aeronautical, and energy, as well as governments and institutions across the world. The SES Networks portfolio includes GovSat, a 50/50 public-private partnership between SES and the Luxembourg government, and O3b, the only non-geostationary system delivering fibre-like broadband services today. Further information is available at: www.ses.com
About World Space Week and the Association
The largest space event on Earth, UN-declared World Space Week is celebrated October 4-10 annually. The largest space event on Earth, World Space Week consists of a myriad of space-related activities held by space agencies, aerospace industry, schools, planetaria, museums, and astronomy clubs in a common time frame to achieve greater student and public impact through synchronization. In 2018, World Space Week included over 5,400 events in 86 nations. World Space Week Association is the global coordinator of World Space Week. An international non-government, non-profit organization led by volunteers, the Association is a permanent observer on the UN Committee on the Peaceful Uses of Outer Space and is supported by voluntary contributions of sponsors around the world.
Further information is available at: www.worldspaceweek.org
View source version on businesswire.com: https://www.businesswire.com/news/home/20190611006082/en/
Contact:
Francesca De Florio SES Tel. +352 710 725 500 francesca.deflorio@ses.com
Maruška Strah WSWA Tel. +39 392 517 41 89 mstrah@worldspaceweek.org
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer House of Code for at styrke teknologi- og dataløsninger26.6.2026 20:01:00 CEST | Pressemeddelelse
Andersen Consulting forstærker sine kompetencer inden for teknologisk transformation gennem en samarbejdsaftale med House of Code, en global virksomhed med hovedkvarter i USA, der specialiserer sig i datadrevne platforme, automatisering og agentbaserede ai-løsninger. House of Code blev stiftet i 2001 og udvikler softwareløsninger samt yder rådgivning til energihandels- og finanssektoren med kunder, der spænder over hedgefonde, kapitalfonde og forsyningsvirksomheder. Virksomheden besidder dyb ekspertise inden for energihandel og risikostyring og hjælper organisationer med systemimplementering, forretningstransformation, dataautomatisering og ai-underbygget modernisering af arbejdsgange. Deres proprietære platform, Enterprise Platform for Integrated Compliance (EPIC), skaber en mere effektiv datastyring, automatiserer rapporteringsprocesser, forbedrer den driftsmæssige gennemsigtighed på tværs af virksomhedssystemer og skaber et fundament for opbygning af intelligente, agentbaserede arbe
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 20:00:00 CEST | Press release
Receives AI Governance & Risk Excellence Award at OpenAI Partner SummitCapco’s UK AI Lab wins OpenAI Codex Hackathon Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solutio
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
